A new company formed to commercialize research that aims to prevent cancer from spreading or recurring is raising $60.75 million in its first venture financing. . . . → Read More: Company to Stop Cancer Spread, Relapse Raises $60.8M
|
|||||
|
|
 2 comments - (Comments are closed)  Finance, Intellectual property  biomedical, biotechnology, cancer, entrepreneurs, equity, investment, licensing, life sciences, medical device, pharmaceuticals, university, venture capital 
A new venture capital fund is being formed to finance start-up companies developing technologies that aim to extend healthy human life spans. . . . → Read More: Venture Fund Formed to Back Longevity Research One comment - (Comments are closed) Finance biomedical, biotechnology, engineering, entrepreneurs, equity, investment, life sciences, mathematics, medical device, pharmaceuticals, physical sciences, software, U.K., venture capital 
Apple makes more than phones, and while the volume of sales in these other company units is smaller, the percentage gains from last year are healthy. . . . → Read More: Infographic – Apple Phone Sales Down, Wearables Up One comment - (Comments are closed) Finance engineering, equity, medical device, software, statistics 
A new initiative is researching modified immune system cells to treat T-cell lymphoma, a type of blood-related cancer, with a simpler, lower-cost process. . . . → Read More: Foundation Backs Engineered T-Cells to Treat Lymphoma One comment - (Comments are closed) Finance, New products biomedical, biotechnology, cancer, clinical trials, grant, life sciences, pharmaceuticals, university 
Medical researchers are developing a treatment for a frequent side-effect of Parkinson’s disease drugs using a corrective RNA molecule to reverse the condition. . . . → Read More: RNA Therapy Studied for Parkinson’s Side Effects Comments are closed Finance biomedical, biotechnology, genomics, grant, life sciences, NIH, pharmaceuticals, preclinical, university 
Yesterday, we reported on 2018 being a banner year for venture capital, but the New York Times says a movement of entrepreneurs is looking for other ways to raise money. . . . → Read More: Start-Ups Saying No Thanks to Venture Capital 
Venture funding last year totaled $99.5 billion, the largest annual outlay since 2000. . . . → Read More: Infographic – Venture Finance Reaching Dot-Com Levels 
A company spun-off from a university medical materials lab received start-up funds to develop a non-opioid surgical pain therapy, including a clinical trial. . . . → Read More: Spin-Off Gains Seed Funds for Non-Opioid Pain Drug Comments are closed Finance, New products biomedical, Canada, chemistry, clinical trials, engineering, entrepreneurs, equity, investment, licensing, life sciences, materials science, pharmaceuticals, physical sciences, university, venture capital 
A developer of therapies derived from cannabis is sponsoring a 3-year basic and translational research program, including clinical trials, at Imperial College London. . . . → Read More: Start-up Funds Univ. Medical Cannabis Research One comment - (Comments are closed) Finance, Joint ventures/collaborations biomedical, cancer, clinical trials, entrepreneurs, Europe, FDA, grant, life sciences, pharmaceuticals, preclinical, U.K., university 
Drug maker Eli Lilly and Company is acquiring a developer of cancer therapies that target specific genetic alterations rather than tumors in the body. . . . → Read More: Lilly Buys Precision Cancer Company in $8B Deal Comments are closed Finance biomedical, biotechnology, cancer, clinical trials, equity, genomics, investment, life sciences, merger, pharmaceuticals |
||||
|
Copyright © 2019 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||